Increased prescription rate of anti‐infective agents after diagnosis of myelodysplastic syndromes

The a priori risk for infections in patients with myelodysplastic syndromes (MDS) is unknown. This study examines prescription rates of anti‐infective agents in MDS patients before and after diagnosis, in both in‐ and outpatient settings, to provide information on infection management in clinical pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozema, Johanne, Hoogendoorn, Mels, Potma, Iris, ten Seldam, Inge, Veeger, Nic J. G. M., Kibbelaar, Robby E., van de Loosdrecht, Arjan A., van Roon, Eric N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematologic Malignancy ‐ Myeloid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422012/
https://www.ncbi.nlm.nih.gov/pubmed/36051088
http://dx.doi.org/10.1002/jha2.422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422012/
https://www.ncbi.nlm.nih.gov/pubmed/36051088
http://dx.doi.org/10.1002/jha2.422

Ejemplares similares